Loading clinical trials...
Loading clinical trials...
A Phase I Study to Evaluate the Single and Multiple-dose Pharmacokinetics of Intravenous Trappsol Cyclo (HP-Beta-CD) in Patients With Niemann-Pick Disease Type C (NPC-1) and the Effects of Dosing Upon Biomarkers of NPC Disease
Conditions
Interventions
Hydroxypropyl-beta-cyclodextrin
Locations
2
United States
UCSF Benioff Children's Hospital Oakland
Oakland, California, United States
Atlantic Health System/Morristown Medical Center
Morristown, New Jersey, United States
Start Date
October 11, 2017
Primary Completion Date
February 10, 2020
Completion Date
February 10, 2020
Last Updated
February 21, 2021
Lead Sponsor
Cyclo Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions